Latest Funding News

VanEck Investments Limited has announced final dividends for a suite of its Australian and global bond ETFs, reaffirming steady income streams for investors ahead of February payments.

Janus Henderson Investors has announced the final distribution for its Sustainable Credit Active ETF, delivering 18.3819 cents per unit for January 2025. Key dates for investors include the ex-date on 3 February and payment on 13 February.

Entyr Limited has received a $3.79 million R&D tax incentive payment for its innovative thermal desorption project targeting rubber waste, reinforcing its position in sustainable tyre recycling technology.

Redivium Limited remains suspended from ASX trading following a failed entitlement offer and key director resignations, raising fresh doubts about its financial viability and governance.

Redivium Limited has successfully completed the formalities for listing a €25 million green bond, aimed at accelerating its sustainable battery recycling projects across Europe, including the UK, Czech Republic, and Romania.

Redivium Limited’s recent entitlement offer failed to meet the minimum subscription, leading to its cancellation and full refunds to investors. The company now pivots towards a green bond funding strategy to support its battery recycling ambitions.

Regis Resources has established a $300 million revolving credit facility, replacing its previous term loan to enhance financial flexibility and liquidity amid a strong banking syndicate backing.

Maas Group Holdings has announced a fresh on-market share buyback of up to 10% of its issued capital, signaling strong confidence in its financial health and future prospects.

Calix Limited has successfully closed its Share Purchase Plan, raising $2.1 million to complement a prior $20 million institutional placement, strengthening its balance sheet to advance key environmental technology projects.

Biotron Limited reported a robust net cash inflow of $1.095 million for the December 2024 quarter, driven largely by government grants, supporting its operational stability despite ongoing R&D expenses.

Medlab Clinical reports a near-empty cash balance and zero receipts in Q2 2025, while actively pursuing a business acquisition ahead of its ASX removal date.

Peregrine Gold Limited has successfully raised $1.74 million through its recent entitlement offer, securing key shareholder support to advance exploration at its Tin Can Trend project.